Michael A. Narachi
2013
In 2013, Michael A. Narachi earned a total compensation of $3.5M as President, Chief Executive Officer and Member of the Board of Directors at Orexigen Therapeutics, a 21% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $515,625 |
|---|---|
| Option Awards | $2,378,286 |
| Salary | $625,000 |
| Other | $7,926 |
| Total | $3,526,837 |
Narachi received $2.4M in option awards, accounting for 67% of the total pay in 2013.
Narachi also received $515.6K in non-equity incentive plan, $625K in salary and $7.9K in other compensation.
Rankings
In 2013, Michael A. Narachi's compensation ranked 2,082nd out of 12,286 executives tracked by ExecPay. In other words, Narachi earned more than 83.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,082 out of 12,286 | 83rd |
Division Manufacturing | 682 out of 4,612 | 85th |
Major group Chemicals And Allied Products | 193 out of 1,462 | 87th |
Industry group Drugs | 129 out of 1,156 | 89th |
Industry Pharmaceutical Preparations | 109 out of 890 | 88th |
Source: SEC filing on May 27, 2016.
Narachi's colleagues
We found four more compensation records of executives who worked with Michael A. Narachi at Orexigen Therapeutics in 2013.
2013
Joseph Hagan
Orexigen Therapeutics
Former Chief Business and Financial Officer
2013
Preston Klassen
Orexigen Therapeutics
Executive Vice President, Global Product Development
2013
Heather Turner
Orexigen Therapeutics
General Counsel
2013
Mark Booth
Orexigen Therapeutics